Search results for "From ACP Journal Club"


 
Results 71 - 80 of about 131 for "From ACP Journal Club".
Sort by: Relevance | Newest | Oldest

Metformin use was linked to hospitalization for acidosis at 6 y only in patients with eGFR

The results are in accordance with guidelines and regulatory policy recommendations that have extended use of metformin to individuals with mild to moderate kidney impairment, an ACP Journal Club commentary said.
https://diabetes.acponline.org/archives/2018/11/09/6.htm
9 Nov 2018

Exenatide did not reduce major cardiovascular outcomes in type 2 diabetes

While exenatide can be considered a second-line option for patients with type 2 diabetes and some may prefer its once-weekly dosing, those at high cardiovascular risk should receive agents with demonstrated cardiovascular benefit, according to an ACP Journal Club commentary.
https://diabetes.acponline.org/archives/2018/01/12/10.htm
12 Jan 2018

Continuous glucose monitoring reduced hypoglycemia over 6 months

The positive results of a trial of continuous glucose monitoring in type 1 diabetes patients ages 60 years and older support recommending the technology to this group, according to an ACP Journal Club commentary.
https://diabetes.acponline.org/archives/2020/12/11/10.htm
11 Dec 2020

Review: Dapagliflozin increases, and empagliflozin reduces, adverse renal events in type 2 diabetes

A commentary called for the findings to be confirmed with randomized controlled trials designed specifically to evaluate the effect of SGLT2 inhibitors on the kidneys.
https://diabetes.acponline.org/archives/2017/08/11/6.htm
11 Aug 2017

In type 2 diabetes, a primary care–led weight management program increased weight loss and diabetes remission at 2 years

Primary care practices that want to adopt such an intervention for their patients will need a dietician or practice nurse to deliver an intensive weight loss program, noted an ACP Journal Club commentary.
https://diabetes.acponline.org/archives/2019/09/13/8.htm
13 Sep 2019

In type 2 diabetes, intensive glucose control for 5.6 years did not differ from usual care for major CV events at 14 years

These long-term follow-up data show no legacy effect from intensive glucose control on cardiovascular (CV) events, differing from the results of the United Kingdom Prospective Diabetes Study, an ACP Journal Club commentary noted.
https://diabetes.acponline.org/archives/2019/10/11/8.htm
11 Oct 2019

In uncontrolled type 2 diabetes, adjunctive semaglutide reduced HbA1c and body weight vs sitagliptin

The trial showed that an oral glucagon-like peptide-1–receptor analogue improved glycemic control compared to a dipeptidyl peptidase 4 inhibitor, but gastrointestinal side effects and cost remain barriers to use of the former class.
https://diabetes.acponline.org/archives/2019/09/13/7.htm
13 Sep 2019

Self-monitoring of blood glucose did not improve HbA1c or QOL at 1 year in non-insulin-treated type 2 diabetes

The randomized controlled trial adds to the evidence about routine use of self-monitoring of blood glucose for all patients with type 2 diabetes, according to an ACP Journal Club commentary.
https://diabetes.acponline.org/archives/2017/11/10/7.htm
10 Nov 2017

In type 2 diabetes with increased CV risk, tirzepatide reduced HbA1c vs. glargine at 52 wk

Once tirzepatide is approved by the FDA, it may be a treatment option for patients with type 2 diabetes who are overweight, have high risk for atherosclerotic cardiovascular (CV) disease, and have no gastrointestinal symptoms, an ACP Journal Club summary said.
https://diabetes.acponline.org/archives/2022/03/11/7.htm
11 Mar 2022

In metformin-treated type 2 diabetes mellitus, weekly dulaglutide was noninferior to daily liraglutide for HbA1c levels

Patients whose diabetes was inadequately controlled on metformin showed similar weight loss, improvement in HbA1c, and adverse events whether they took dulaglutide or liraglutide, a trial found.
https://diabetes.acponline.org/archives/2014/12/12/6.htm
12 Dec 2014

Result Page: Prev   3   4   5   6   7   8   9   10   11   12   Next